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Abstract The origin of fibrotic cells within connective
tissue is unclear. For example, the extent to which
microvascular pericytes contribute to the number of myofi-
broblasts present in dermal fibrosis in uncertain. Connective
tissue growth factor (CTGF/CCN2) is a marker and mediator
of fibrosis. In this report, we use an antibody recognizing
CCN2 to assess the cell types in mouse dermis which
express CCN2 in the bleomycin model of skin scleroderma.
Control (PBS injected) and fibrotic (bleomycin-injected)
dermis was examined for CCN2, α-smooth muscle actin
(α-SMA) (to detect myofibroblasts), and NG2 (to detect
pericytes) expression. Consistent with previously published
data, CCN2 expression was largely absent in the dermis of
control mice. However, upon exposure to bleomycin, CCN2
was observed in the dermis. Cells that expressed CCN2 were
α−SMA-expressing myofibroblasts. Approximately 85%
of myofibroblasts were NG2-positive, CCN2-expressing
pericytes, indicating that pericytes significantly contributed
to the presence of myofibroblasts in sclerotic dermis. Thus
CCN2 is induced in fibrotic skin, correlating with the
induction of myofibroblast induction. Moreover, CCN2-
expressingpericytessignificantlycontributetotheappearance
of myofibroblasts in bleomycin-induced skin scleroderma.
Keywords CTGF.CCN2.Connectivetissuegrowthfactor.
Scleroderma.Fibrosis.Pericyte
Introduction
Tissue repair involves the reconstitution of connective
tissue by a specialized from of fibroblast, termed the
myofibroblast (Tomasek et al. 2002). This cell type is
characterized by the expression of the pro-contractile
protein α-smooth muscle actin (α-SMA). Fibrosis can be
considered to arise due to a persistence of the tissue repair
program. Indeed, fibrotic lesions are populated large
numbers of myofibroblasts (Desmouliere et al. 2005).
Moreover, fibroblasts isolated from lesions of scleroderma
patients show a persistently activated myofibroblast
phenotype (Chen et al. 2005). The exact origin of
myofibroblasts in tissue repair and fibrosis is unclear,
but a significant percentage of may derive from
pericytes surrounding blood vessels or from local
recruitment of fibroblasts (Hinz et al. 2007;R a j k u m a r
et al. 2006). For example, recently we found that, in
cutaneous wounds in mice, approximately 30% of the
myofibroblasts were also pericytes (Kapoor et al. 2008).
However, the extent to which pericytes contribute to skin
fibrosis is unclear.
CCN2 (Connective tissue growth factor/CCN2) is a
member of the CCN family of proteins (Leask and
Abraham 2006). CCN2 is an adhesive protein which acts
through integrins and heparan sulfate-containing proteo-
glycans (HSPGs) (Lau and Lam 1999; Gao and Brigstock
2004). CCN2 is expressed in mesenchymal cells during
development and wound healing, and is characteristically
over-expressed in fibrotic diseases (Blom et al. 2002;
Leask and Abraham 2006). The majority of studies on
CCN2 gene regulation have been conducted in cell
culture; for example, in fibroblasts, CCN2 is induced by
transforming growth factor β through Smads, ets-1 and
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Beek et al. 2006). CCN2 overexpression in dermal
fibroblasts isolated from scleroderma patients, in contrast,
is independent of TGFβ signaling and dependent on
endothelin-1 and Sp1 (Holmes et al. 2003; Shi-Wen et
al. 2007). In vivo, CCN2 is not normally expressed in
adult mouse dermis, but is induced in myofibroblasts
post-wounding (Kapoor et al. 2008). However, the
whether the appearance of CCN2 correlates with myofi-
broblast induction in skin fibrosis is unknown.
Although mouse model perfectly recapitulates the
characteristics of scleroderma, the bleomycin model skin
fibrosis is often used as a model of scleroderma (Wu and
Varga 2008). CCN2 mRNA is induced in bleomycin-
induced lung fibrosis (Lasky et al. 1998; Ponticos et al.
2009), but whether CCN2 protein is induced in response
to bleomycin-induced dermal fibrosis is unclear. More-
over, the cell types within the dermis that express
CCN2 in response to bleomycin is unknown.
In this study, we subject mice to the bleomycin-induced
model of skin scleroderma. We investigate the expression of
CCN2 using an anti-CCN2 antibody. We also detect the
presence of myofibroblasts and pericytes using appropriate
markers. Hence, we provide a first careful analysis of the cell
types expressing CCN2 in skin and generate new insights into
the origin of myofibroblasts during skin fibrosis.
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Fig. 1 CCN2 promoter is expressed in myofibroblasts in response to
bleomycin. Skin of mice treated with PBS or bleomycin was fixed,
sectioned, and stained with DAPI to detect nuclei, anti-α-SMA antibody
to detect myofibroblasts and anti-CCN2 promoter antibody (10×
magnification of dermal tissue). The percentage of fibroblasts within
the wound that were α−SMA positive, CCN2- positive, and CCN2/
α-SMA positive was calculated as described in Methods. Representative
data from n=4 wounds from 4 separate animals are shown
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CCN2 is induced in myofibroblasts in response
to bleomycin
The cell types expressing CCN2 in fibrosis are unclear. To
address this issue, C57/BL6 mice were subjected to subcuta-
neous injections of PBS or bleomycin over 28 days. As we
wereinterestedintheexpressionofCCN2inconnectivetissue
and in the origin of myofibroblasts within connective tissue,
we focused our studies specifically on the dermis. When
control PBS-injected skin was examined, a few CCN2-
positive cells were detected in the dermis (Fig. 1, CCN2,
PBS). Conversely, in response to bleomycin, CCN2 expres-
sion was strongly induced in the dermis (Fig. 1, CCN2, bleo).
Similar patterns of expression were observed when tissue
sections were stained with anti-α-SMA antibody to detect
the presence of myofibroblasts (Fig. 1, α-SMA). Cells
expressing CCN2 were also α−SMA positive (Fig. 1,
merge). Collectively, these data indicate that CCN2 is
expressed in myofibroblasts in response to bleomycin.
CCN2 is expressed in pericytes post-bleomycin treatment
To assess the precise contribution of pericytes to the
activated fibroblasts present in skin in response to bleomycin
and to investigate whether CCN2 promoter was expressed
pericytes, we performed double immunolabeling of tissue
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Fig. 2 CCN2 promoter is expressed in pericytes in response to
bleomycin. Skin of mice treated with PBS or bleomycin was fixed,
sectioned, and stained with DAPI to detect nuclei, anti-NG2 antibody
to detect myofibroblasts and anti-CCN2 antibody (10× magnification
of dermal tissue). The percentage of fibroblasts within the wound that
were CCN2 positive, NG2 positive, and both NG2/CCN2-positive
was calculated as described in Methods. Representative data from n=4
wounds from 4 separate animals per time point is shown
CCN2 expression in bleomycin-induced skin fibrosis 27sections with an anti-CCN2 antibody and an anti-NG2
antibody to detect pericytes. NG2 is routinely used a
pericyte-specific marker in the literature (Ozerdem and
Stallcup 2004; Salvucci et al., 2009 and references
therein). We found that 60% of the cells in the tissue
were NG2-expressing pericytes (Fig. 2). Double-labeling
experiments revealed that CCN2 was expressed in
pericytes (Fig. 2).
The majority of the myofibroblasts in bleomycin-induced
skin scleroderma are pericytes
To assess whether pericytes contributed to the number of
myofibroblasts in bleomycin-induced fibrotic tissue, tissue
sections were stained with both anti-NG2 and anti-α-SMA
antibodies. In response to bleomycin, ~75% of the cells in
the tissue were both NG2-positive and α−SMA positive
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Fig. 3 A subset of myofibroblasts are perictyes in response to
bleomycin. Skin of mice treated with PBS or bleomycin was fixed,
sectioned, and stained with DAPI to detect nuclei, anti-α-SMA
antibody to detect myofibroblasts and anti-CCN2 antibody (10×
magnification of dermal tissue). The percentage of fibroblasts within
the wound that were α−SMA positive, NG2 positive, and both NG2/
α-SMA positive was calculated as described in Methods. Note that
essentially all cells in the wound area are myofibroblasts. Represen-
tative data from n=4 wounds from 4 separate animals per time point is
shown
28 S. Liu et al.(Fig. 3). Collectively, these results not only support the
notion that CCN2 is an excellent marker of myofibro-
blast activation in response to fibrotic stimuli, but also
suggest that pericytes can significantly contribute to the
presence of myofibroblasts within fibrotic lesions.
Discussion
Elevated, constitutive CCN2 expression is a hallmark of
fibrotic disease and can be considered a surrogate marker of
fibrosis (Blom et al. 2002; Leask and Abraham 2006). In
response to tissue injury, CCN2 is induced in myofibroblasts
(Kapoor et al. 2008). In this report, we extend these studies
and show that, in response to the bleomycin-induced model
of skin fibrosis, CCN2 is expressed in myofibroblasts.
Moreover, pericytes, which are believed to contribute to the
total number of myofibroblasts in fibrotic tissue (Hinz et al.
2007; Rajkumar et al. 2006), also express CCN2 and
comprise the majority of fibroblasts activated in response
to bleomycin. Our data are consistent with previously
published data showing that CCN2 is expressed in pericytes
in culture as well as in retinas of diabetic patients (Shiwen et
al. 2009; Kuiper et al. 2004). Our data are also consistent
with a previous study from our group showing that
CCN2, type I collagen protein and mRNAs encoding
other fibrotic proteins such as fibronectin are upregulated
in cultured pericytes (Shiwen et al. 2009). Our results
also support the notion that CCN2 is a faithful marker of
fibrogenesis in vivo (Blom et al. 2002; Leask and
Abraham 2006). It is interesting to note that recently it
was shown that an anti-CCN2 antibody alleviated
bleomycin-induced lung fibrosis (Ponticos et al. 2009)
and siRNA against CCN2 reversed CCl4-induced liver
fibrosis (Brigstock 2009). Thus CCN2 may be both a
marker and a mediator of fibrosis (Grotendorst 1997;
Leask and Abraham 2004, 2006). Finally, our data suggest
that pericytes are a significant source of myofibroblasts in
skin fibrosis. Collectively, our results may be useful in the
future for uncovering new strategies aimed at modulating
(myo)fibroblast biology during fibrosis.
Materials and methods
Bleomycin-induced skin fibrosis
Bleomycin (Sigma) was diluted to 0.1 U/ml with PBS, and
filter sterilized. 100 µl of bleomycin or PBS was injected
subcutaneously into a single location on the shaved back of
C57/BL6 mice once daily for 4 weeks (Yamamoto et al.
1999) Mice were the killed using CO2, and skin was
collected for immunohistochemical analysis. Tissue samples
used for this experiment were generated in a previously
published study (Liu et al. 2009).
Immunofluorescence
Tissue sections (0.5 µm) were cut using a microtome (Leica),
collected on Superfrost Plus slides (Fisher Scientific),
dewaxedinxyleneandrehydratedbysuccessiveimmersion
in descending concentrations of alcohol. Tissue sections
were then incubated with mouse serum for 30 min, washed
with PBS and incubated with primary antibodies for 1 hour
at room temperature. Primary antibodies used alone (single
immunofluorescence) or in combination (double immuno-
fluorescence) were: rabbit anti-CCN2 (anti-CCN2; 1:100
dilution, Abcam), mouse anti-NG2 (pericyte marker, 1:100
dilution, Chemicon), mouse anti-alpha-smooth muscle
actin (α-SMA, 1:100 dilution, Sigma). Double immuno-
fluorescence for α-SMA and NG2 was performed using
rabbit polyclonal antibody for α-SMA (Abcam) and mouse
antibodyforNG2.SectionswerewashedwithPBS,incubated
with appropriate fluorescent secondary antibodies (Jackson
Immunoresearch) for one hour at room temperature, washed
with PBS, mounted using DAPI and photographed using
Zeiss fluorescence microscope and Northern Eclipse software
(Empix). Six independent fields were examined per data
point.
Sections undergoing double immunofluorescence were
photographed at 10× magnification. To detect number of
α-SMA, CCN2 or NG2 positive cells, total number of cells/
mm
2 were counted. The percentage α-SMA, CCN2 and
NG2 positive cells/mm
2 were then calculated.
Results are expressed as the mean ± SEM. P<0.05 was
considered statistically significant (*; Student’s t test).
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